[
  {
    "drug": "Minocycline",
    "disease": "inhalational anthrax",
    "classification": "VALIDATED",
    "evidence": "FDA-approved; CDC 2023 lists minocycline"
  },
  {
    "drug": "Demeclocycline",
    "disease": "inhalational anthrax",
    "classification": "PLAUSIBLE",
    "evidence": "Same class but not in CDC guidelines"
  },
  {
    "drug": "Doxycycline",
    "disease": "ichthyosis vulgaris",
    "classification": "PLAUSIBLE",
    "evidence": "Anti-inflammatory but no disease evidence"
  },
  {
    "drug": "Minocycline",
    "disease": "early lyme disease",
    "classification": "VALIDATED",
    "evidence": "RCT shows equals penicillin"
  },
  {
    "drug": "Doxycycline",
    "disease": "meningococcal infection",
    "classification": "IMPLAUSIBLE",
    "evidence": "Bacteriostatic; requires bactericidal therapy"
  },
  {
    "drug": "Minocycline",
    "disease": "dysentery",
    "classification": "IMPLAUSIBLE",
    "evidence": "40%+ Shigella tetracycline resistance"
  },
  {
    "drug": "Demeclocycline",
    "disease": "meningococcal infection",
    "classification": "IMPLAUSIBLE",
    "evidence": "Bacteriostatic; inappropriate for meningococcal"
  },
  {
    "drug": "Oxytetracycline",
    "disease": "listeriosis",
    "classification": "IMPLAUSIBLE",
    "evidence": "Wrong class; 61% resistance in L. monocytogenes"
  },
  {
    "drug": "Tetracycline",
    "disease": "granuloma inguinale",
    "classification": "VALIDATED",
    "evidence": "Historical efficacy vs K. granulomatis"
  },
  {
    "drug": "Oxytetracycline",
    "disease": "brucellosis",
    "classification": "VALIDATED",
    "evidence": "WHO-recommended class; same mechanism as doxycycline"
  },
  {
    "drug": "Doxycycline",
    "disease": "dysentery",
    "classification": "PLAUSIBLE",
    "evidence": "79% prophylaxis but resistance limits treatment"
  },
  {
    "drug": "Demeclocycline",
    "disease": "dysentery",
    "classification": "IMPLAUSIBLE",
    "evidence": "Same resistance issues, inferior PK"
  },
  {
    "drug": "Oxytetracycline",
    "disease": "actinomycosis",
    "classification": "PLAUSIBLE",
    "evidence": "Some susceptibility but penicillin is gold standard"
  },
  {
    "drug": "Doxycycline",
    "disease": "pyelonephritis",
    "classification": "IMPLAUSIBLE",
    "evidence": "35-60% urinary excretion; not in IDSA guidelines"
  },
  {
    "drug": "Minocycline",
    "disease": "pyelonephritis",
    "classification": "PLAUSIBLE",
    "evidence": "ESBL step-down only; 2025 study"
  },
  {
    "drug": "Oxytetracycline",
    "disease": "sinusitis",
    "classification": "IMPLAUSIBLE",
    "evidence": "Not in any modern guidelines; obsolete"
  },
  {
    "drug": "Fludarabine",
    "disease": "DLBCL",
    "classification": "PLAUSIBLE",
    "evidence": "Salvage/CAR-T prep; not first-line"
  },
  {
    "drug": "Fludarabine",
    "disease": "mast cell leukemia",
    "classification": "IMPLAUSIBLE",
    "evidence": "No evidence; midostaurin/avapritinib standard"
  },
  {
    "drug": "Cladribine",
    "disease": "small intestine cancer",
    "classification": "IMPLAUSIBLE",
    "evidence": "No evidence; wrong cancer type"
  },
  {
    "drug": "Fluorouracil",
    "disease": "cholangiocarcinoma",
    "classification": "VALIDATED",
    "evidence": "NCCN: FOLFOX second-line standard"
  },
  {
    "drug": "Bleomycin",
    "disease": "germ cell testicular cancer",
    "classification": "VALIDATED",
    "evidence": "BEP regimen core; 95% complete response"
  },
  {
    "drug": "Cladribine",
    "disease": "small lymphocytic lymphoma",
    "classification": "PLAUSIBLE",
    "evidence": "Historical efficacy; superseded by BTK inhibitors"
  },
  {
    "drug": "Bleomycin",
    "disease": "endometrial cancer",
    "classification": "IMPLAUSIBLE",
    "evidence": "Not in any endometrial guidelines"
  },
  {
    "drug": "Bleomycin",
    "disease": "esophageal cancer",
    "classification": "IMPLAUSIBLE",
    "evidence": "Not in NCCN esophageal guidelines"
  },
  {
    "drug": "Fluorouracil",
    "disease": "renal carcinoma",
    "classification": "IMPLAUSIBLE",
    "evidence": "4-6% response; obsolete vs TKIs/immunotherapy"
  },
  {
    "drug": "Bleomycin",
    "disease": "carcinoma (generic)",
    "classification": "VALIDATED",
    "evidence": "FDA-approved for SCC head/neck/cervix/penis, testicular"
  },
  {
    "drug": "Bevacizumab",
    "disease": "head and neck cancers",
    "classification": "PLAUSIBLE",
    "evidence": "Phase III: improved PFS but not OS"
  },
  {
    "drug": "Trabectedin",
    "disease": "biliary tract cancer",
    "classification": "IMPLAUSIBLE",
    "evidence": "No evidence; sarcoma drug"
  },
  {
    "drug": "Carmustine",
    "disease": "biliary tract cancer",
    "classification": "IMPLAUSIBLE",
    "evidence": "No evidence; brain tumor drug"
  },
  {
    "drug": "Fluorouracil",
    "disease": "head and neck cancers",
    "classification": "VALIDATED",
    "evidence": "NCCN standard cisplatin+5-FU regimen"
  },
  {
    "drug": "Fludarabine",
    "disease": "lymphoplasmacytic lymphoma",
    "classification": "PLAUSIBLE",
    "evidence": "Superior to chlorambucil; now 2nd-line to BTK-i"
  },
  {
    "drug": "Methylprednisolone",
    "disease": "bursitis",
    "classification": "VALIDATED",
    "evidence": "FDA-approved; intrabursal injection standard"
  },
  {
    "drug": "Methylprednisolone",
    "disease": "ABPA",
    "classification": "VALIDATED",
    "evidence": "Standard of care per ISHAM guidelines"
  },
  {
    "drug": "Betamethasone",
    "disease": "secondary adrenocortical insufficiency",
    "classification": "IMPLAUSIBLE",
    "evidence": "CAUSES condition; inverse indication"
  },
  {
    "drug": "Corticotropin",
    "disease": "lichen planus",
    "classification": "PLAUSIBLE",
    "evidence": "Historical evidence; replaced by modern CS"
  },
  {
    "drug": "Corticotropin",
    "disease": "vernal keratoconjunctivitis",
    "classification": "PLAUSIBLE",
    "evidence": "FDA-approved for allergic eye; not first-line"
  },
  {
    "drug": "Methylprednisolone",
    "disease": "angioedema",
    "classification": "PLAUSIBLE",
    "evidence": "Adjunctive for histaminergic only; not bradykinin"
  },
  {
    "drug": "Ketoconazole",
    "disease": "aspergillosis",
    "classification": "IMPLAUSIBLE",
    "evidence": "Not active against Aspergillus per StatPearls"
  },
  {
    "drug": "Amphotericin B",
    "disease": "chronic mucocutaneous candidiasis",
    "classification": "VALIDATED",
    "evidence": "100% efficacy in CMC; azole-resistant strains"
  },
  {
    "drug": "Amphotericin B",
    "disease": "chromomycosis",
    "classification": "VALIDATED",
    "evidence": "WHO recommended; 87.5% cure with DAT"
  },
  {
    "drug": "Amphotericin B",
    "disease": "Chagas disease",
    "classification": "IMPLAUSIBLE",
    "evidence": "Not standard; benznidazole/nifurtimox first-line"
  },
  {
    "drug": "Azithromycin",
    "disease": "hospital-acquired pneumonia",
    "classification": "IMPLAUSIBLE",
    "evidence": "Minimal gram-negative coverage; wrong spectrum"
  },
  {
    "drug": "Ketoconazole",
    "disease": "central precocious puberty",
    "classification": "PLAUSIBLE",
    "evidence": "Off-label anti-androgen; clinical evidence exists"
  },
  {
    "drug": "Clotrimazole",
    "disease": "vulvovaginitis",
    "classification": "VALIDATED",
    "evidence": "CDC first-line; 80-90% cure rate"
  },
  {
    "drug": "Lidocaine",
    "disease": "eczema",
    "classification": "PLAUSIBLE",
    "evidence": "Emerging: blocks NaV1.8+ neurons; experimental"
  },
  {
    "drug": "Lidocaine",
    "disease": "microscopic polyangiitis",
    "classification": "IMPLAUSIBLE",
    "evidence": "No evidence; procedural artifact"
  },
  {
    "drug": "Bupivacaine",
    "disease": "uveitis",
    "classification": "IMPLAUSIBLE",
    "evidence": "No therapeutic role; procedural artifact"
  },
  {
    "drug": "Bupivacaine",
    "disease": "bronchopulmonary dysplasia",
    "classification": "IMPLAUSIBLE",
    "evidence": "No evidence; procedural artifact"
  },
  {
    "drug": "Bupivacaine",
    "disease": "pulmonary tuberculosis",
    "classification": "IMPLAUSIBLE",
    "evidence": "No antimycobacterial activity"
  },
  {
    "drug": "Lidocaine",
    "disease": "acquired TTP",
    "classification": "IMPLAUSIBLE",
    "evidence": "No evidence; procedural artifact"
  },
  {
    "drug": "Salicylic acid",
    "disease": "ichthyosis",
    "classification": "VALIDATED",
    "evidence": "Established keratolytic; FDA-approved indication"
  },
  {
    "drug": "Azathioprine",
    "disease": "acquired TTP",
    "classification": "PLAUSIBLE",
    "evidence": "Second-line immunosuppressive for remission"
  },
  {
    "drug": "Paroxetine",
    "disease": "bulimia nervosa",
    "classification": "PLAUSIBLE",
    "evidence": "SSRI class evidence but only fluoxetine FDA-approved"
  },
  {
    "drug": "Papaverine",
    "disease": "unstable angina",
    "classification": "PLAUSIBLE",
    "evidence": "FDA-approved for vascular spasm; not first-line"
  },
  {
    "drug": "Propylthiouracil",
    "disease": "acromegaly",
    "classification": "IMPLAUSIBLE",
    "evidence": "Wrong mechanism; antithyroid not GH"
  },
  {
    "drug": "Levothyroxine",
    "disease": "dyslipidemia",
    "classification": "PLAUSIBLE",
    "evidence": "Valid only for hypothyroidism-caused dyslipidemia"
  },
  {
    "drug": "Calcitriol",
    "disease": "FGF23 hypophosphatemic rickets",
    "classification": "VALIDATED",
    "evidence": "Conventional standard therapy"
  },
  {
    "drug": "Phenobarbital",
    "disease": "chronic pain",
    "classification": "IMPLAUSIBLE",
    "evidence": "No analgesic properties; may worsen pain"
  },
  {
    "drug": "Phenobarbital",
    "disease": "agoraphobia",
    "classification": "IMPLAUSIBLE",
    "evidence": "Obsolete; replaced by SSRIs/benzodiazepines"
  }
]